MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer
Ontology highlight
ABSTRACT: MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer
PROVIDER: PRJNA1256417 | ENA |
REPOSITORIES: ENA
ACCESS DATA